Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin Core 32.0 enters release-candidate testing with faster block validation and wallet updates.

Protocol Fundamentals
21 Sep 2026
Crypto news
View Source
Neutral
Bitcoin Core 32.0 enters release-candidate testing with faster block validation and wallet updates.

Bitcoin Core version 32.0 has entered release-candidate testing as of September 14, with a targeted stable release date of October 10. Key improvements include parallel database reads that speed up block validation without affecting Bitcoin's block production rate, and wallet commands now default to using PSBT version 2 for partially signed transactions, enhancing wallet workflows. The update also fixes security issues related to unsafe wallet names and excessive memory use from unauthenticated HTTP requests. This release focuses on software performance and security without changing Bitcoin’s consensus rules or requiring network-wide coordination, allowing node operators and developers to test and adopt the new version at their own pace.

Bitcoin Core 32's final testing phase is underway as of September 21, 2026, 23:51 WIB. For readers following major cryptocurrencies, here is Pluang's market snapshot as of that time: out of 50 priced major cryptocurrencies, 41 rose and 8 fell today. Notable movers include EOS at Rp12.649 with an 8.13% increase, AXS at Rp19.053 with a 7.31% rise despite a 90% sell order activity, and SOL at Rp2.090.485 up 6.64% with a 62% buy order activity. EOS's 8.13% gain stands out as the most notable figure.

More News

Boeing faces 737 MAX production delays but analysts see potential 32% stock upside.

Boeing faces 737 MAX production delays but analysts see potential 32% stock upside.

Boeing is experiencing ongoing production challenges with its 737 MAX aircraft, causing delays and a recent 3.7% stock drop. Jefferies lowered its price target to $265, still implying a 32% upside from current prices, reflecting cautious optimism. Ba...

Analyst Insights
Neutral
38 minutes ago
Alkermes' ALKS7290 shows strong early results in ADHD treatment, boosting stock by 2.3%.

Alkermes' ALKS7290 shows strong early results in ADHD treatment, boosting stock by 2.3%.

Alkermes plc's drug ALKS7290 demonstrated significant improvement in ADHD symptoms in a Phase 1b trial, with patients showing a 14- to 19-point gain on a 54-point scale within two weeks. This outperforms typical placebo effects, which range from 6 to...

Market News
Bullish
3 hours ago
BrandPilot AI to attend Marketecture Live 2026, focusing on AI and transparency in digital advertising.

BrandPilot AI to attend Marketecture Live 2026, focusing on AI and transparency in digital advertising.

BrandPilot AI announced its participation in Marketecture Live 2026 in Chicago, an event that gathers advertising, media, and technology professionals to discuss industry developments. The company aims to engage in discussions about artificial intell...

Market News
Neutral
4 hours ago
Meta shares jump 12% on strong early adoption of Muse AI assistant and higher price target

Meta shares jump 12% on strong early adoption of Muse AI assistant and higher price target

Meta Platforms shares surged 12% to $747.91 following early success of its new Muse AI assistant, which topped Apple's US App Store with over 730,000 downloads shortly after launch. Wells Fargo raised Meta's price target to $796, citing strong moment...

Market News
Bullish
4 hours ago
Ventas posts strong Q2 2026 growth, raises full-year guidance on senior housing strength.

Ventas posts strong Q2 2026 growth, raises full-year guidance on senior housing strength.

Ventas reported solid Q2 2026 results with 10% same-store cash NOI growth and 9% normalized FFO/share growth, driven by its dominant senior housing portfolio. Management raised its 2026 FFO/share guidance and acquisition targets, citing a strong bala...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App